HIF1A and cancer: Therefore, the deviation of glucose to the PPP, orchestrated by factors like HIF-1α in the TME, is a critical mechanism by which cancer cells acquire hallmarks of malignancy, making HIF-1α and PPP enzymes promising targets for therapeutic intervention (137, 138, 147–149).